Hepatic electrical stimulation reduces blood glucose in diabetic rats

Neurogastroenterology and Motility

Volumn 22, Issue 10, 2010, Pages

  Chen, J ^a   Pasricha, P J ^b   Yin, J ^a   Lin, L ^a   Chen, J D Z ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

blood glucose; diabetes; electrical stimulation; gastrointestinal hormones; glycemic control; hyperglycemia

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ELECTRODE; ELECTROSTIMULATION THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEPATIC ELECTRICAL STIMULATION; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE TRANSIT TIME; LIPID METABOLISM; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; FASTING; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL TRANSIT; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; LIVER; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER;

EID: 77956324743     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01556.x     Document Type: Article

References (40)

1. Combettes M, Kargar C. Newly approved and promising antidiabetic agents. Therapie 2007 62 : 293 310.
2. Edelman SV. Importance of glucose control. Med Clin North Am 1998 82 : 665 687.
3. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997 127 : 788 795.
4. Umpierrez GE, Gonzalez A, Umpierrez D, Pimentel D. Diabetes mellitus in the Hispanic/Latino population: an increasing health care challenge in the United States. Am J Med Sci 2007 334 : 274 282.
5. Kuo P, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. Drugs 2007 67 : 1671 1687.
6. Virally M, Blickle JF, Girard J, Halimi S, Simon D, Guillausseau PJ. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes Metab 2007 33 : 231 244.
7. Sakaguchi T, Yamaguchi K. The effect of electrical stimulation of the hepatic branch of the vagus nerve on the secretion of gastric acid in the rat. Neurosci Lett 1979 13 : 25 8.
8. Sakaguchi T, Yamaguchi K. Effects of electrical stimulation of the hepatic vagus nerve on the plasma insulin concentration in the rat. Brain Res 1979 164 : 314 316.
9. Rozman J, Zorko B, Bunc M, Zitko M. Stimulation of nerves innervating the dog's pancreas. Artif Organs 2002 26 : 241 243.
10. Rozman J, Bunc M, Zorko B. Modulation of hormone secretion by functional electrical stimulation of the intact and incompletely dysfunctional dog pancreas. Braz J Med Biol Res 2004 37 : 363 370.
11. Takahashi A, Ishimaru H, Ikarashi Y, Kishi E, Maruyama Y. Effects of hepatic nerve stimulation on blood glucose and glycogenolysis in rat liver: studies with in vivo microdialysis. J Auton Nerv Syst 1996 61 : 181 185.
12. Chen J. Mechanisms of action of the implantable gastric stimulator for obesity. Obes Surg 2004 14 : S28 32.
13. Zhang J, Chen JD. Systematic review: applications and future of gastric electrical stimulation. Aliment Pharmacol Ther 2006 24 : 991 1002.
14. Jungermann K, Gardemann A, Beuers U et al. Regulation of liver metabolism by the hepatic nerves. Adv Enzyme Regul 1987 26 : 63 88.
15. Lautt WW. Afferent and efferent neural roles in liver function. Prog Neurobiol 1983 21 : 323 348.
16. Shimazu T. Neuronal regulation of hepatic glucose metabolism in mammals. Diabetes Metab Rev 1987 3 : 185 206.
17. Chen J YJ, Lin L, Pasricha PJ, Chen JDZ. Hepatic electrical stimulation reduces blood glucose in both Type-I and Type-II diabetic rats. (Poster of distinction). Gastroenterology 2009 136 : s1.
18. Liu J, Qiao X, Micci MA, Pasricha PJ, Chen JD. Improvement of gastric motility with gastric electrical stimulation in STZ-induced diabetic rats. Digestion 2004 70 : 159 166.
19. Ryan ME, Ramamurthy NS, Sorsa T, Golub LM. MMP-mediated events in diabetes. Ann NY Acad Sci 1999 878 : 311 334.
20. Shibata T, Takeuchi S, Yokota S, Kakimoto K, Yonemori F, Wakitani K. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br J Pharmacol 2000 130 : 495 504.
21. Picherit C, Horcajada MN, Mathey J et al. Isoflavone consumption does not increase the bone mass in osteopenic obese female zucker rats. Ann Nutr Metab 2003 47 : 70 7.
22. Abell T, McCallum R, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003 125 : 421 428.
23. Chen JD, Qian L, Ouyang H, Yin J. Gastric electrical stimulation with short pulses reduces vomiting but not dysrhythmias in dogs. Gastroenterology 2003 124 : 401 409.
24. Liu J, Qiao X, Chen JD. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci 2004 49 : 729 737.
25. Ouyang H, Yin J, Chen JD. Therapeutic potential of gastric electrical stimulation for obesity and its possible mechanisms: a preliminary canine study. Dig Dis Sci 2003 48 : 698 705.
26. Sacks DA, Greenspoon JS, Fotheringham N. Could the fasting plasma glucose assay be used to screen for gestational diabetes?. J Reprod Med 1992 37 : 907 909.
27. Lee YS, Shin S, Shigihara T et al. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes 2007 56 : 1671 1679.
28. Mari A, Sallas WM, He YL et al. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes. J Clin Endocrinol Metab 2005 90 : 4888 4894.
29. Sallam HS, Oliveira HM, Gan HT, Herndon DN, Chen JD. Ghrelin improves burn-induced delayed gastrointestinal transit in rats. Am J Physiol Regul Integr Comp Physiol 2007 292 : R253 7.
30. Peter P, Nuttall SL, Kendall MJ. Insulin resistance - the new goal J Clin Pharm Ther 2003 28 : 167 174.
31. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl 2002 3 : 47 51.
32. D'Alessio DA, Vahl TP. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am J Physiol Endocrinol Metab 2004 286 : E882 90.
33. Stoffers DA, Kieffer TJ, Hussain MA et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000 49 : 741 748.
34. Drucker DJ. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 2003 144 : 5145 5148.
35. Lautt WW. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J Pharmacol Sci 2004 95 : 9 17.
36. Shimazu T. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 1981 20 : 343 356.
37. Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994 107 : 1848 1855
38. Gunnarsson PT, Winzell MS, Deacon CF et al. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006 147 : 3173 3180.
39. Schirra J, Houck P, Wank U, Arnold R, Goke B, Katschinski M. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Gut 2000 46 : 622 631.
40. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002 122 : 531 544.